{"product_id":"scripps-39th-annual-new-treatments-in-chronic-liver-disease-2025","title":"Scripps 39th Annual New Treatments in Chronic Liver Disease 2025","description":"\u003cdiv class=\"grid-x grid-margin-x\"\u003e\n\u003cdiv class=\"cell initial-12 medium-8\"\u003e\n\u003cdiv class=\"pnllearningActivityInformationClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnllearningActivityInformation_0\"\u003e\n\u003cdiv class=\"pnlLearningActivityInformationDescriptionClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnlLearningActivityInformationDescription_0\"\u003e\n\u003cdiv class=\"pnllearningActivityInformationClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnllearningActivityInformation_0\"\u003e\n\u003cdiv class=\"pnlLearningActivityInformationDescriptionClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnlLearningActivityInformationDescription_0\"\u003e\n\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-element_type=\"widget\" data-id=\"bbb44b8\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-371ff86 elementor-widget elementor-widget-heading\" data-element_type=\"widget\" data-id=\"371ff86\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"custom-single-product product type-product post-465185 status-publish first instock product_cat-hot-books product_cat-anesthesiology product_cat-cardiology product_cat-hematology product_cat-medical-reference-terminology product_cat-vascular-medicine has-post-thumbnail sale downloadable virtual taxable purchasable product-type-simple\" id=\"product-465185\"\u003e\n\u003cdiv class=\"afk-single-product-outer\"\u003e\n\u003cdiv class=\"akf-p-f-box d-flex f-wrap j-c-b\"\u003e\n\u003cdiv class=\"akf-right\"\u003e\n\u003cdiv class=\"woo-tab-container custom woo-tc-j\"\u003e\n\u003cdiv class=\"tabcontent active\" id=\"descriptionTab\"\u003e\n\u003cdiv class=\"prod-desc\"\u003e\n\u003ch1 class=\"product_title entry-title\"\u003eScripps 39th Annual New Treatments in Chronic Liver Disease 2025\u003c\/h1\u003e\n\u003cstrong\u003e+ Include: 14 videos + 12 pdfs, size: 3.56 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: hepatologists, gastroenterologists, internists, transplant specialists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e39TH ANNUAL New Treatments in Chronic Liver Disease\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eMarch 15-16, 2025 Coronado Island Marriott Coronado, California\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real-world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problemsin the treatment of liver diseases.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eEducational Objectives\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eAfter attending this live activity, participants should be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCite new strategies for identifying and managing metabolic liver disease.\u003c\/li\u003e\n\u003cli\u003eReview updated goals and guidelines for curing Delta Hepatitis, HBV and HCV.\u003c\/li\u003e\n\u003cli\u003eDiscuss potential new treatments for alcohol related liver disease.\u003c\/li\u003e\n\u003cli\u003eSummarize novel markers and therapies in PBC and PSC.\u003c\/li\u003e\n\u003cli\u003eEvaluate liver masses and new therapeutic options for HCC.\u003c\/li\u003e\n\u003cli\u003eEmploy strategies for treating and managing ascites and hepatorenal syndrome.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eThe Scripps 39th Annual \u003cem\u003eNew Treatments in Chronic Liver Disease\u003c\/em\u003e Conference (2025) is best for hepatologists, gastroenterologists, internists, transplant specialists, and allied health professionals who want CME‑accredited updates on the latest therapies, diagnostics, and management strategies for chronic liver disease.\u003cbr\u003e\u003ch3\u003e Who Should Attend\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eHepatologists and gastroenterologists managing patients with cirrhosis, hepatitis, NAFLD\/NASH, and other chronic liver conditions.\u003c\/li\u003e\n\u003cli\u003eTransplant hepatologists and surgeons involved in liver transplantation and advanced liver failure care.\u003c\/li\u003e\n\u003cli\u003eInternal medicine and primary care physicians who need practical updates for managing liver disease in outpatient settings.\u003c\/li\u003e\n\u003cli\u003eResidents, fellows, and trainees preparing for board exams or subspecialty practice in hepatology or GI.\u003c\/li\u003e\n\u003cli\u003eNurses, nurse practitioners, and physician assistants working in hepatology, gastroenterology, or transplant programs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e What You’ll Learn\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eLatest pharmacologic therapies for viral hepatitis, autoimmune hepatitis, NAFLD\/NASH, and cholestatic liver diseases.\u003c\/li\u003e\n\u003cli\u003eAdvances in diagnostics: non‑invasive fibrosis assessment, imaging, and biomarkers.\u003c\/li\u003e\n\u003cli\u003eManagement of cirrhosis and portal hypertension including complications such as ascites, variceal bleeding, and hepatic encephalopathy.\u003c\/li\u003e\n\u003cli\u003eUpdates in liver transplantation: patient selection, immunosuppression, and outcomes.\u003c\/li\u003e\n\u003cli\u003eEmerging therapies and clinical trials shaping the future of chronic liver disease treatment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003ch3\u003eSaturday, March 15, 2025\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e7 a.m. Registration, Breakfast \u0026amp; View Exhibits\u003c\/li\u003e\n\u003cli\u003e8 a.m. Welcome \u0026amp; Introduction Identifying And Managing Metabolic Liver Disease\u003c\/li\u003e\n\u003cli\u003e8:15 a.m. Use of Surrogate Markers and Algorithms to Identify High Risk Patients and Optimize Outcomes\u003c\/li\u003e\n\u003cli\u003e8:45 a.m. Lifestyle Recommendations in Clinical Practice\u003c\/li\u003e\n\u003cli\u003e9:30 a.m. Incretins for Patients with MASH and T2D\u003c\/li\u003e\n\u003cli\u003e10 a.m. Break \u0026amp; View Exhibits\u003c\/li\u003e\n\u003cli\u003e10:30 a.m. Drug Development for MASH\u003c\/li\u003e\n\u003cli\u003e11:15 a.m. Panel Discussion\/Q\u0026amp;A\u003c\/li\u003e\n\u003cli\u003eNoon Non-CME Lunch Symposium Hosted by Gilead Sciences Evolving Therapies For Advanced Liver Care\u003c\/li\u003e\n\u003cli\u003e1 p.m. CAMs for HBV: How Do They Work and How Should We Use Them?\u003c\/li\u003e\n\u003cli\u003e1:30 p.m. New Guidance for Hepatitis B and C\u003c\/li\u003e\n\u003cli\u003e2 p.m. All Things Itchy: PBC, PSC, and Pruritus\u003c\/li\u003e\n\u003cli\u003e2:30 p.m. Break \u0026amp; View Exhibits\u003c\/li\u003e\n\u003cli\u003e2:45 p.m. Alcohol Hepatitis\u003c\/li\u003e\n\u003cli\u003e3:15 p.m. Panel Discussion\/Q\u0026amp;A\u003c\/li\u003e\n\u003cli\u003e3:45 p.m. Adjourn\u003c\/li\u003e\n\u003cli\u003e4 p.m. Welcome Reception\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSunday, March 16, 2025\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e7 a.m. Breakfast \u0026amp; View Exhibits\u003c\/li\u003e\n\u003cli\u003e7:55 a.m. Welcome \u0026amp; Announcements ESLD, HCC And Transplantation\u003c\/li\u003e\n\u003cli\u003e8 a.m. Refractory Hepatic Encephalopathy\u003c\/li\u003e\n\u003cli\u003e8:30 a.m. Mock HCC Tumor Board\u003c\/li\u003e\n\u003cli\u003e9:30 a.m. Systemic Therapies for HCC\u003c\/li\u003e\n\u003cli\u003e10 a.m. Break \u0026amp; View Exhibits\u003c\/li\u003e\n\u003cli\u003e10:30 a.m. WILLIAM S. HAUBRICH LECTURE: ASOs and siRNAs for HBV—How Do They Work and How Should We Use Them?\u003c\/li\u003e\n\u003cli\u003e11:30 a.m. Panel Discussion\/Q\u0026amp;A\u003c\/li\u003e\n\u003cli\u003eNoon Final Adjournment\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954534486114,"sku":"MED-AMB05516","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Scripps-39th-Annual-New-Treatments-in-Chronic-Liver-Disease-2025.jpg?v=1779379145","url":"https:\/\/meducourse.com\/products\/scripps-39th-annual-new-treatments-in-chronic-liver-disease-2025","provider":"Meducourse","version":"1.0","type":"link"}